Drug shortage
Acyclovir Tablet · Apotex Corp.
FDA drug shortage · To Be Discontinued · updated Apr 26, 2024
Key facts
| Generic name | Acyclovir Tablet |
|---|---|
| Company | Apotex Corp. |
| Presentation | Tablet, 400 mg/1 (NDC 60505-5306-1) |
| Dosage form | Tablet |
| Strength | 400 mg/1 |
| Status | To Be Discontinued |
| Therapeutic category | Antiviral |
| Package NDCs | 60505-5306-1 |
| First posted | Apr 26, 2024 |
| Last updated | Apr 26, 2024 |
| Discontinued | Apr 26, 2024 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: